跳至主要内容
临床试验/CTRI/2025/11/097902
CTRI/2025/11/097902尚未招募不适用

Lactate Albumin ratio as a prognostic marker in children with septic shock

Madhumitha Sadasivam1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2025年12月2日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
62
试验地点
1

研究概览

简要总结

Sepsis is defined as life threatening organ dysfunction caused by dysregulated host immune response to infection.Sepsis in children is associated with high morbidity and mortality rates. Early identification, appropriate resuscitation and management are therefore critical to optimize the outcome for children with sepsis .Traditional markers like lactate and albumin have individually shown prognostic value in sepsis but affected by various physiological and pathological conditions . Lactate albumin ratio (LAR) has gained attention as simple, easily obtainable and cost-effective biomarker that may offer better prognostic accuracy than either parameter alone. Unlike complex scoring system like PRISM III (Paediatric Risk of Mortality), which require multiple clinical and laboratory variables, LAR can be rapidly derived using routinely available blood test results even in peripheral or low- resource settings. Despite its proven value in adult sepsis, data on LAR in Paediatric sepsis are limited especially in India.

研究设计

研究类型
Observational

入排标准

年龄范围
1.00 Month(s) 至 18.00 Year(s)(—)
性别
All

入选标准

  • Children aged 1 month to 18 years of age admitted with diagnosis of septic shock in PICU.

排除标准

  • Children with Chronic liver disease, chronic kidney disease, nephrotic syndrome, protein losing enteropathy, severely malnourished, previously diagnosed with IEM having hyperlactatemia(mitochondrial disorder, disorder of pyruvate metabolism, disorder of gluconeogenesis, fatty acid oxidation), glycogen storage disease, Severe Acute Malnutrition.

研究者

发起方
Madhumitha Sadasivam
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Madhumitha Sadasivam

MAHE

研究点 (1)

Loading locations...

相似试验